Finally, some hope for people with Retinitis Pigmentosa (RP)

While retinal damage was apparent in all RP patients over the course of 4 years, those receiving FloraGLO lutein experienced a slower decline in midperipheral vision compared to the controls

Encouraging new treatment for blindness being studied.

A treatment that is currently FDA approved to treat seizures, migraines and bipolar disorder is being evaluated as a possible treatment for retinitis pigmentosa (RP).

Gene therapy study shows promise for Retinitis pigmentosa

A study published in the April 2010 issue of the Federation of American Societies for Experimental Biology (FASEB) Journal details the results of using nucleic acid nanoparticles to restore the vision in mice.